共 50 条
- [1] StockWatch: FDA Panel Enables Accelerated OK for Biogen ALS Drug Genetic Engineering and Biotechnology News, 2023, 5 (01): : 256 - 261
- [10] Biomarker data prove critical for ALS drug evaluation at FDA Nature Medicine, 2022, 28 : 2226 - 2227